HubSpot, Inc.
270.88USD
+3.6900 (+1.38%)
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on HUBS.
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $3.27▼ | $3.45 | 2 | 1 |
| Next quarter | $4.09▲ | $3.94 | 3 | 1 |
| Current year | $13.3▲ | $13.1 | 5 | 0 |
| Next year | $16.85▲ | $15.63 | 9 | 2 |
Beat in 4 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $3.02 | $3.26 | +0.24 (+8.1%) |
| 2026-03-31 | $2.47 | $2.72 | +0.25 (+10.2%) |
| 2025-12-31 | $2.99 | $3.09 | +0.10 (+3.4%) |
| 2025-09-30 | $2.59 | $2.66 | +0.07 (+2.9%) |
572 ratings from 43 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| BTIG | Maintained | Buy | $250 $300 | Oct 23, 2026 |
| Barclays | Downgraded from Overweight | Equal-Weight | $240 | Oct 12, 2026 |
| JP Morgan | Downgraded from Overweight | Neutral | $268 $240 | Oct 8, 2026 |
| Cantor Fitzgerald | Reiterated | Neutral | $200 | Oct 7, 2026 |
| Needham | Reiterated | Buy | $300 | Oct 6, 2026 |
| Raymond James | Downgraded from Outperform | Market Perform | — | Oct 5, 2026 |
| BMO Capital | Maintained | Market Perform | $215 $250 | Sep 21, 2026 |
| Truist Securities | Maintained | Buy | $230 $275 | Sep 21, 2026 |
| Stephens & Co. | Maintained | Equal-Weight | $251 $255 | Sep 21, 2026 |
| TD Cowen | Maintained | Hold | $285 $260 | Sep 18, 2026 |
| UBS | Maintained | Buy | $250 $290 | Sep 18, 2026 |
| RBC Capital | Reiterated | Outperform | $300 | Sep 18, 2026 |
| Needham | Reiterated | Buy | $300 | Sep 18, 2026 |
| Cantor Fitzgerald | Reiterated | Neutral | $200 | Sep 18, 2026 |
| BTIG | Reiterated | Buy | $250 | Sep 18, 2026 |
| Stifel | Maintained | Hold | $200 $225 | Sep 11, 2026 |
| RBC Capital | Reiterated | Outperform | $300 | Sep 11, 2026 |
| TD Cowen | Maintained | Hold | $220 $285 | Sep 1, 2026 |
| Citigroup | Maintained | Neutral | $217 $210 | Aug 7, 2026 |
| BMO Capital | Downgraded from Outperform | Market Perform | $230 $215 | Aug 7, 2026 |
| Canaccord Genuity | Maintained | Buy | $335 $300 | Aug 6, 2026 |
| TD Cowen | Maintained | Hold | $250 $220 | Aug 6, 2026 |
| Macquarie | Maintained | Neutral | $190 | Aug 6, 2026 |
| RBC Capital | Maintained | Outperform | $350 $300 | Aug 6, 2026 |
| Wolfe Research | Downgraded from Outperform | Peer Perform | — | Aug 6, 2026 |
135 filings from 20 insiders · 13 buy / 8 sell over 6m
Officers and directors of HUBS, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Halligan BrianDirector | Sellindirect | 8.5k | $239.57 | $2.04M | Oct 20, 2026 |
| Bueker KathrynOfficer, Chief Financial Officer | Tax | 781 | $217.45 | $170k | Oct 1, 2026 |
| Halligan BrianDirector | Tax | 371 | $217.45 | $81k | Oct 1, 2026 |
| Rangan YaminiDirector; Officer, Chief Executive Officer & Pres | Tax | 2.1k | $217.45 | $465k | Oct 1, 2026 |
| Shah DharmeshDirector; Officer, Chief Technology Officer | Tax | 436 | $217.45 | $95k | Oct 1, 2026 |
| Halligan BrianDirector | Sellindirect | 8.5k | $245.64 | $2.09M | Sep 15, 2026 |
| Rangan YaminiDirector; Officer, Chief Executive Officer & Pres | Tax | 2.6k | $251.11 | $658k | Sep 1, 2026 |
| Bueker KathrynOfficer, Chief Financial Officer | Tax | 1.1k | $251.11 | $270k | Sep 1, 2026 |
| Shah DharmeshDirector; Officer, Chief Technology Officer | Tax | 578 | $251.11 | $145k | Sep 1, 2026 |
| Halligan BrianDirector | Tax | 158 | $251.11 | $40k | Sep 1, 2026 |
| FISHER ERIKA ASHLEYOfficer, Chief Legal Officer | Tax | 322 | $251.11 | $81k | Sep 1, 2026 |
| HALLIGAN BRIAN PDirector | Sellindirect | 8.5k | $219.50 | $1.87M | Aug 18, 2026 |
| DISCHLER GERALDDirector | Buy | 925 | $215.93 | $200k | Aug 10, 2026 |
| DISCHLER GERALDDirector | Grant | 1.0k | — | — | Aug 5, 2026 |
| FISHER ERIKA ASHLEYOfficer | Sell | 702 | $235.22 | $165k | Aug 4, 2026 |
| HALLIGAN BRIAN PDirector | Sellindirect | 8.5k | $221.09 | $1.88M | Jul 21, 2026 |
| BERRY MICHAEL JDirector | Grant | 1.2k | — | — | Jun 16, 2026 |
| SHIH CLARADirector | Grant | 1.2k | — | — | Jun 16, 2026 |
| NORRINGTON LORRIE MDirector | Grant | 1.2k | — | — | Jun 16, 2026 |
| JOHNSON CLAIRE D'OYLY-HUGHESDirector | Grant | 1.2k | — | — | Jun 16, 2026 |
No analyst notes on HUBS yet.
Analyst Ratings
30 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 3 | 9 | 22 | 0 | 1 | Hold2.63 |
| 1 mo ago | 6 | 9 | 19 | 0 | 1 | Buy2.46 |
| 2 mo ago | 6 | 9 | 18 | 0 | 1 | Buy2.44 |
| 3 mo ago | 8 | 16 | 10 | 0 | 1 | Buy2.14 |
Members whose judged calls on HUBS have played out most reliably.
No settled calls on HUBS yet. Nobody has filed a call with a deadline on it.
A member is listed once they have three judged calls on a name.
A call with a target is judged on whether the price reaches it by the deadline, counting each day's high (a buy) or low (a sell) from the day after the call was made. A call without one is judged on whether the price at the close on the deadline is higher (a buy) or lower (a sell) than the price the call was made at: the live price when it was saved, for a call made with Make a call, or the last close before the day it was filed, for a call made in a note. Not against the market or an index.
A percentage appears once five calls have reached their deadline. A target reached sooner is shown as played out early, and counts toward the percentage when its deadline passes, because a miss cannot be known before then.
A member’s prediction, judged on price history · not investment advice